Not applicableUnknownNCT04197076What this trial is testingNeoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIBWho this might be right forNon Small Cell Lung Cancer Shanghai Chest Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06779539What this trial is testingNeoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer West China Hospital 33
Testing effectiveness (Phase 2)UnknownNCT04202809What this trial is testingPhase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.Who this might be right forNSCLC, Stage III University Hospital, Essen 90
Testing effectiveness (Phase 2)Ended earlyNCT00232206What this trial is testingTrial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung CancerWho this might be right forNon-small-Cell Lung Carcinoma Providence Health & Services 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819578What this trial is testingToripalimab Plus Sacituzumab Tirumotecan as Neoadjuvant Therapy for Resectable NSCLCWho this might be right forNon-Small Cell Lung Cancer Shaodong Hong 30
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05132985What this trial is testingNeoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung AdenocarcinomaWho this might be right forNSCLCEGF-R Positive Non-Small Cell Lung Cancer Liaoning Cancer Hospital & Institute 45
Testing effectiveness (Phase 2)Ended earlyNCT03574818What this trial is testingNecitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001Who this might be right forSquamous Cell Lung Cancer Montefiore Medical Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04685070What this trial is testingNeoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Stage III Shanghai Pulmonary Hospital, Shanghai, China 56
Large-scale testing (Phase 3)Looking for participantsNCT06623422What this trial is testingPembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Who this might be right forCarcinoma, Non-Small-Cell Lung Merck Sharp & Dohme LLC 680
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06109402What this trial is testingPerioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung CancerWho this might be right forStage II-IIIB(N2) Non-small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 160
Testing effectiveness (Phase 2)Study completedNCT03197467What this trial is testingNeoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer (NSCLC) AIO-Studien-gGmbH 30
Early research (Phase 1)Ended earlyNCT03255083What this trial is testingDS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer (NSCLC) Daiichi Sankyo 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07402070What this trial is testingIBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung CancerWho this might be right forResectable Stage II-III Non-small Cell Lung Cancer Innovent Biologics (Suzhou) Co. Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01443078What this trial is testingNeoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)Who this might be right forLung Cancer Memorial Sloan Kettering Cancer Center 42
Not applicableLooking for participantsNCT06743581What this trial is testingStudy of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy Centre hospitalier de l'Université de Montréal (CHUM) 24
Large-scale testing (Phase 3)Ended earlyNCT00273507What this trial is testingNeoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3Who this might be right forNon-small Cell Lung Cancer Rigshospitalet, Denmark 270
Large-scale testing (Phase 3)Study completedNCT00003901What this trial is testingPrognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by SurgeryWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 1,310
Testing effectiveness (Phase 2)Looking for participantsNCT05987826What this trial is testingStudy of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLCWho this might be right forNon-Small Cell Lung Cancer Shanghai Zhongshan Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT06431633What this trial is testingStudy of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.Who this might be right forLung DiseasesCarcinoma, Non-Small-Cell LungResectable Lung Non-Small Cell Carcinoma Fundación GECP 129